Healio3h
Ruxolitinib cream 1.5% effective, safe for greater AD surface area in pediatric patients
Ruxolitinib cream 1.5% was safe and effective for the treatment of children and adolescents with a 35% or greater body surface areas affected by atopic dermatitis, according to a study.Ruxolitinib ...
FDA approves first new class of painkiller in 20 years, a non-addictive opioid alternative
The medication offers relatively modest pain relief, underscoring the challenges of finding new ways to manage pain.
Byrdie on MSN4h
Jordan Chiles Uses This $10 Lotion to Make Her Skin Glow on Competition Days
Athlete Beat In this recurring franchise, we speak with beauty-forward athletes about their game-day routines. From the ...
Us Weekly5h
Shoppers Say This $10 Neck Cream Is ‘Good for Middle-Aged Necks’
Middle-aged shoppers took to Amazon raving about this neck cream and how much it firmed and lifted their sagging skin - ...
Mahakumbh 2025: Top health & wellness items that you must have in your travel kit
Have a happy and safe trip to Mahakumbh 2025 by choosing the right travel essentials. Make sure to have these health and wellness products in your travel kit.
WGN Radio11h
New type of non-opioid pain medication approved by FDA
( The Hill) – The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults.
FDA approves new type of non-opioid pain medication
The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults. The new development is ...